Eye Care Specialists
Kingston, Pennsylvania 18704
4 studies enrolling now · 30 studies all time
What they study most
Aphakia, Bacterial Infections, Blepharoplasty, Cataract, Cataract Extraction, Cataracts, Corneal Edema After Cataract Surgery, Diabetes Mellitus, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy, Dry Eye
Studies at this site
- A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio — Recruiting now
- Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses — Recruiting now
- Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
- Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™ — Recruiting now
- A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery — Completed
- Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD) — Completed
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Running, not enrolling
- Evaluation of Clareon Vivity/Vivity Toric — Completed
- Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema — Running, not enrolling
- Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration — Running, not enrolling
- A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — Completed
- A Study of NGM621 in Participants With Geographic Atrophy — Completed
- Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects — Completed
- Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses — Completed
- A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. — Stopped early
- Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study — Completed
- A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery — Completed
- Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma — Completed
- Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens — Completed
- Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants — Status unconfirmed
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
- Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease — Completed
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain — Completed
- Clinical Investigation of the Next Generation Intraocular Lens — Completed
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study — Completed
- Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study — Withdrawn before enrolling
- The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora — Completed
- Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery — Completed
- DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery — Completed
- DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery — Stopped early